Daily FNArena News - Australia

All | Australia | Book Reviews | Commodities | ESG Focus | FYI | International | Small Caps | SMSFundamentals | Technicals | Treasure Chest

Previous Stories

Stockbrokers See Value Among Small Caps

Jul 05 2010

There’s value up for grabs among Australia’s small caps stocks, stockbrokers say.


New Trends and Challenges For Oz Retailers

Jul 02 2010

Westpac suggests Australia is undergoing a sea change in consumer behaviour, which brokers see as having an impact on operations for retailers of consumer discretionary items in particular.


PanAust Leveraged To Copper Prices And Production Growth

Jul 02 2010

BA Merrill Lynch has initiated coverage on PanAust with a Buy rating, attracted to the combination of leverage to copper prices and production growth going forward.


The RSPT Is Dead, Long Live MRRT

Jul 02 2010

The Australian government and the miners and energy companies have reached an agreement on a new tax regime.


Economy Watch: Oz May Data Suggest RBA On Hold

Jul 01 2010

A snapshot of economist responses to today’s as expected Australian retail sales and weaker than expected building approvals data for May.


Earnings Risks and Stockbroker Favourites

Jul 01 2010

GS analysts don’t think RSPT concessions will boost mining stocks, while Citi calculates earnings risks and others line up their favourites.


On New Dividend Rules, Tax On CSM LNG, And Retail Banking

Jun 30 2010

RBS evaluates stocks impacted by changing dividend rules while JP Morgan weighs up the RSPT against the PRRT and Morgan Stanley warns of lower earnings for retail banking.


Latest US Plasma Data Add To More Doubt On CSL

Jun 29 2010

The latest plasma market data in the US suggest some IVIG volume growth but brokers have offered mixed reactions.


The Reject Shop Set For Solid Earnings Growth

Jun 28 2010

Management of The Reject Shop has confirmed earnings guidance and brokers are encouraged by expansion plans.


On LNG, Pathology And Recruitment Stocks

Jun 25 2010

Citi assesses the current state of Australia’s LNG prospects while Deutsche Bank revisits pathology stocks and RBS downgrades recruitment stocks.



Analyse The Market From A Different Angle